These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34851465)

  • 41. Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom.
    Alfaqawi F; Lip PL; Elsherbiny S; Chavan R; Mitra A; Mushtaq B
    Eye (Lond); 2017 Apr; 31(4):650-656. PubMed ID: 28106887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis.
    Pavesio C; Heinz C
    Eye (Lond); 2022 Jun; 36(6):1231-1237. PubMed ID: 34117380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results.
    Elbarky AM
    Eur J Ophthalmol; 2021 Nov; 31(6):3196-3202. PubMed ID: 33426902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes.
    Currie CJ; Holden SE; Berni E; Owens DR
    Curr Med Res Opin; 2017 Oct; 33(sup2):19-31. PubMed ID: 28881143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
    Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R
    Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.
    Merrill PT; Holekamp N; Roth D; Kasper J; Grigorian R;
    Am J Ophthalmol; 2023 Apr; 248():16-23. PubMed ID: 36223849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinal changes after fluocinolone acetonide implant (ILUVIEN®) for DME: SD-OCT imaging assessment using ESASO classification.
    Leite J; Ferreira A; Castro C; Coelho J; Borges T; Correia N; Pessoa B
    Eur J Ophthalmol; 2024 Jan; 34(1):233-244. PubMed ID: 37475207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in Ganglion Cell Layer Thickness after Treatment with the 0.2 µg/day Fluocinolone Acetonide Implant in Vitrectomized and Nonvitrectomized Eyes with Diabetic Macular Edema.
    Pessoa B; Castro C; Ferreira A; Leite J; Heitor J; Menéres P; Figueira J; Meireles A; Beirão JM
    Ophthalmic Res; 2022; 65(3):310-320. PubMed ID: 35086095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
    Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.
    Shen BY; Punjabi OS; Lowder CY; Sears JE; Singh RP
    Retina; 2013 Apr; 33(4):873-7. PubMed ID: 23407350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries.
    Chakravarthy U; Taylor SR; Koch FHJ; Castro de Sousa JP; Bailey C;
    Br J Ophthalmol; 2019 Aug; 103(8):1072-1077. PubMed ID: 30242062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study.
    Ruiz-Moreno JM; Adán A; Lafuente M; Asencio Durán M; Arias Barquet L; García Layana A; Araiz Iribarren J
    Int Ophthalmol; 2023 Dec; 43(12):4639-4649. PubMed ID: 37697082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.
    Meireles A; Goldsmith C; El-Ghrably I; Erginay A; Habib M; Pessoa B; Coelho J; Patel T; Tadayoni R; Massin P; Atorf J; Augustin AJ
    Eye (Lond); 2017 May; 31(5):684-690. PubMed ID: 28085139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravitreal Fluocinolone Acetonide Implant (ILUVIEN
    Mushtaq Y; Mushtaq MM; Gatzioufas Z; Ripa M; Motta L; Panos GD
    Drug Des Devel Ther; 2023; 17():961-975. PubMed ID: 37020801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex).
    Garweg JG; Baglivo E; Freiberg FJ; Pfau M; Pfister IB; Michels S; Zandi S
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):442-50. PubMed ID: 27479780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis.
    Ajamil-Rodanes S; Testi I; Luis J; Robson AG; Westcott M; Pavesio C
    Br J Ophthalmol; 2022 Feb; 106(2):234-240. PubMed ID: 33243833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease.
    Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA
    Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.